Compare DG & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DG | BNTX |
|---|---|---|
| Founded | 1939 | 2008 |
| Country | United States | Germany |
| Employees | 194000 | 7807 |
| Industry | Department/Specialty Retail Stores | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5B | 24.7B |
| IPO Year | 2008 | 2019 |
| Metric | DG | BNTX |
|---|---|---|
| Price | $124.57 | $96.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 13 |
| Target Price | ★ $139.60 | $133.46 |
| AVG Volume (30 Days) | ★ 2.1M | 1.5M |
| Earning Date | 06-02-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.07% | N/A |
| EPS Growth | ★ 34.05 | N/A |
| EPS | ★ 4.49 | N/A |
| Revenue | ★ $42,724,369,000.00 | N/A |
| Revenue This Year | $7.14 | N/A |
| Revenue Next Year | $4.17 | $3.37 |
| P/E Ratio | $28.03 | ★ N/A |
| Revenue Growth | ★ 5.20 | N/A |
| 52 Week Low | $95.11 | $79.81 |
| 52 Week High | $158.23 | $124.00 |
| Indicator | DG | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 42.40 |
| Support Level | $115.31 | $88.36 |
| Resistance Level | $126.20 | $98.81 |
| Average True Range (ATR) | 4.03 | 3.37 |
| MACD | -0.21 | -1.62 |
| Stochastic Oscillator | 15.21 | 0.55 |
Since its beginning in 1939, Dollar General has grown to become the largest dollar store operator in the United States, with more than 20,000 small-box discount stores across 48 states. The firm generated over $42 billion in fiscal 2025 sales. The retailer maintains a heavy concentration of stores in rural and low-income markets underserved by big-box retailers. It's 11,000 stock-keeping units, including 2,000 priced at $1 or less, span consumables (82% of sales), seasonal items (10%), home products (5%), and apparel (3%). More than 20% of sales are derived from private label.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.